KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Accumulated Expenses (2016 - 2025)

Johnson & Johnson's Accumulated Expenses history spans 17 years, with the latest figure at $8.6 billion for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 108.29% year-over-year to $8.6 billion; the TTM value through Dec 2025 reached $8.6 billion, up 108.29%, while the annual FY2025 figure was $8.6 billion, 108.29% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $8.6 billion at Johnson & Johnson, up from $7.6 billion in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $13.6 billion in Q1 2022 and bottomed at $2.2 billion in Q2 2023.
  • The 5-year median for Accumulated Expenses is $7.9 billion (2025), against an average of $7.6 billion.
  • The largest annual shift saw Accumulated Expenses soared 365.37% in 2022 before it plummeted 82.85% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $3.1 billion in 2021, then soared by 279.94% to $12.0 billion in 2022, then plummeted by 66.59% to $4.0 billion in 2023, then grew by 3.33% to $4.1 billion in 2024, then soared by 108.29% to $8.6 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Accumulated Expenses are $8.6 billion (Q4 2025), $7.6 billion (Q3 2025), and $3.3 billion (Q2 2025).